SEARCH

SEARCH BY CITATION

References

  • Amill, L.A. & Wright, M. (1946) Synthetic folic acid therapy in pernicious anemia. Journal of American Medical Association, 131, 12011207.
  • Angier, R.B., Boothe, J.H., Hutchings, B.L., Mowat, J.H., Semb, J., Stokstad, E.L.R., SubraRow, Y., Waller, C.W., Cosulich, D.B., Fahrenbach, M.J., Hultquist, M.E., Kuh, E., Northey, E.H., Seeger, D.R., Sickels, J.P., Smith, Jr, J.M. (1945) Synthesis of a compound identical with the L. casei factor isolated from liver. Science, 102, 227228.
  • Bannerjee, R.V. & Matthews, R.G. (1990) Cobalamin-dependent methionine synthase. FASEB Journal, 4, 14501459.
  • Bennett, M. (1950) Utilization of homocysteine for growth in the presence of vitamin B12 and folic acid. Journal of Biological Chemistry, 187, 751756.
  • Binkley, S.B., Bird, O.D., Bloom, E.S., Brown, R.A., Calkins, D.G., Camnpbell, C.J., Emmett, A.D., Pfiffner, J.J. (1944) On the vitamin Bc conjugate in yeast. Science, 100, 3637.
  • Blakley, R.L. (1969) The biochemistry of folic acid and related pteridines. In: North Holland Research Monographs, Frontiers of Biology, Vol. 13, pp. 1–569. North Holland Publishing Company, Amsterdam.
  • Boushey, C.J., Beresford, S.A.A., Omenn, G.S., Motulsky, A.G. (1995) A quantitative assessment of plasma homocysteine as a risk factor from vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association, 274, 10451057.
  • Brattstrom, L.E. & Hardebo, J.E. & Hultberg. (1984) Moderate homocysteinaemia: a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke, 15, 10121016.
  • Brattstrom, L.E., Israelsson, B.M., Jeppsson, J.-O., Hultberg, B.L. (1988) Folic acid – an innocuous means to reduce plasma homocysteine. Scandinavian Journal of Clinical Laboratory Investigation, 48, 215221.
  • Carson, N.A.J. & Neill, D.W. (1962) Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Archives of Diseases of Childhood, 37, 505513.
  • Chanarin, I. (1990) The Megaloblastic Anaemias, 3rd edn. Blackwell Scientific, Oxford.
  • Christen, W.G., Ajani, U.A., Glynn, R.J., Hennekens, C.H. (2000) Blood levels of homocysteine and increased risks of cardiovascular disease. Archives of Internal Medicine, 160, 422434.
  • Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., Graham, I. (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. New England Journal of Medicine, 324, 11491155.
  • Clarke, R., Smith, A.D., Jobst, K.A., Refsum, H., Sutton, L., Ueland, P.M. (1998) Folate, vitamin B12 amd serum total homocysteine levels in confirmed Alzheimer's disease. Archives of Neurology, 55, 14491455.
  • Czeizel, A.F. & Dudas, J. (1992) Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New England Journal of Medicine, 327, 18321835.
  • Daly, L.E., Kirke, P.N., Molloy, A.M., Weir, D.G., Scott, J.M. (1995) Folate levels and neural tube defects. Implications for prevention. Journal of the American Medical Association, 274, 215219.
  • Davidson, L.S.P., Davis, L.J., Innes, J. (1942) Megaloblastic anaemia of pregnancy and the puerperium. British Medical Journal, 2, 3134.
  • Davidson, L.S.P., Girdwood, R.H., Innes, E.M. (1947) Folic acid in treatment of sprue syndrome. Lancet, i, 511515.
  • Day, P.L., Langston, W.C., Darby, W.J. (1938) Failure of nicotinic acid to prevent nutritional cytopenia in the monkey. Proceedings of the Society of Experimental Biology and Medicine, 38, 860863.
  • Day, P.L., Mimms, V., Totter, J.R., Stokstad, E.L.R., Hutchings, B.L., Sloan, N.H. (1945) The successful yreatment of vitamin M deficiency in the monkey with highly purified L. casei factor. Journal of Biological Chemistry, 157, 423424.
  • Du Vigneaud, V., Ressler, C., Rachele, J.R. (1950) The biological synthesis of ‘labile methyl groups’. Science, 112, 267271.
  • Farber, S., Diamond, L.K., Mercer, R.D., Sylvester, R.F., Wolff, J.A. (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroyl-glutamic acid (Aminopterin). New England Journal of Medicine, 238, 787793.
  • Firkin, B.G. (2000) Some women pioneers in haematology. British Journal of Haematology, 108, 612.
  • Frosst, P., Blom, H.J., Miles, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., Den Heijer, M., Kluiftmans, L.A.J., Van Den Heuvel, L.P., Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111113.
  • Fullerton, H.W. (1943) Macrocytic anaemia of pregnancy and the puerperium. British Medical Journal, 1, 158160.
  • Gerritsen, T., Vaughn, J.G., Waisman, H.A. (1962) The identification of homocysteine in the urine. Biochemical and Biophysical Research Communications, 9, 493496.
  • Giovannucci, E., Stampfer, M.J., Colditz, G.A., Hunter, D.J., Fuchs, C., Rosner, B.A., Speizer, F.E., Willett, W.C. (1998) Multivitamin use, folate, and colon cancer in women in the nurses' health study. Annals of Internal Medicine, 129, 517524.
  • Graham, I.M., Daley, L.E., Refsum, H.M., Robinson, K., Brattstrom, L.E., Heland, P.M., Palma-Reis, R.J., Boers, G.J.H., Sheahan, R.G., Israelsson, B., Uiterwaal, C.S., Meleady, R., McMaster, D., Verhoef, P., Witteman, J., Rubba, P., Bellet, H., Waatrecht, J.C., De Valk, H.W., Salesluis, A.C., Parrot-Roulaud, F.M., Tan, K.S., Higgins, I., Garcon, D., Medrano, M.J., Evans, A.E., Andria, G. (1997) Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. Journal of the American Medical Association, 277, 19751981.
  • Green, R. & Jacobsen, D.W. (1995) Clinical implications of hyperhomo-cysteinaemia. In: Folate in Health and Disease (ed.by L.B.Bailey), 4, pp. 75122. Marcel Dekker, New York.
  • Hall, B.E. (1947) Discussion of papers on folic acid read at Nineteenth Annual Meeting of Central Society for Clinical Research. Journal of Laboratory and Clinical Medicine, 32, 338339.
  • Hanes, F.M. (1942) Diagnostic criteria and resistance to therapy in the sprue syndrome. American Journal of Medical Science, 204, 436443.
  • Hankley, G.J. & Eikelboom, J.W. (1999) Homocysteine and vascular disease. Lancet, 354, 407413.
  • Heinle, R.W. & Welch, A.D. (1947) Folic acid in pernicious anaemia: failure to prevent neurologic relapse. Journal of the American Medical Association, 133, 739741.
  • Herbert, V. & Zalusky, R. (1962) Interrelation of vitamin B12 and folic acid metabolism: folic acid clearance studies. Journal of Clinical Investigation, 41, 12631276.
  • Hibbard, B.M. (1964) The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. Journal of Obstetrics and Gynaecology British Communication, 71, 529542.
  • Hoffbrand, A.V., Ganeshaguru, K., Lavoie, A., Tattersall, M.H.N., Trippe, E. (1974) Thymidylate concentration in megaloblastic anaemia. Nature, 248, 602604.
  • Hogan, A.G. & Parrott, E.M. (1940) Anaemia in chicks caused by a vitamin deficiency. Journal of Biological Chemistry, 132, 507517.
  • Jacques, P.F., Selhub, J., Bostrom, A.G., Wilson, W.F., Wilson, M.D., Rosenberg, I.H. (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New England Journal of Medicine, 340, 14491454.
  • Kang, S.-S., Wong, P.W.K., Zhou, J., Sora, J., Lessick, M., Ruggie, N., Grcevich, G. (1988) Thermolabile methylene tetrahydrofolate reductase in patients with coronary artery disease. Metabolism, 37, 611613.
  • Killmann, S.-A. (1964) Efect of deoxyuridine on incorporation of tritiated thymidine: difference between normoblasts and megaloblasts. Acta Medica Scandinavica, 175, 483488.
  • Kirke, P.N., Molloy, A.M., Daly, L.E., Burke, H., Weir, D.G., Scott, J.M. (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Quarterly Journal of Medicine, 86, 703708.
  • Kutzback, C. & Stokstad, E.L.R. (1967) Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochimica Biophysica Acta, 139, 217220.
  • Laurence, K.M., James, N., Miller, M.H., Tennant, G.B., Campbell, H. (1981) Double-blind randomised controlled trial of folate treatment before conception or recurrence of neural tube defects. British Medical Journal, 282, 15091511.
  • Lavoie, A., Tripp, E., Hoffbrand, A.V. (1974) The effect of vitamin B12 deficiency on methylfolate metabolism and pteroylpoly-glutamate synthesis in human cells. Clinical Science and Molecular Medicine, 47, 617630.
  • McCulley, K. (1969) Vascular pathology of homocysteinaemia: implications for the pathogenesis of arterosclerosis. American Journal of Pathology, 56, 111128.
  • Malinow, M.R., Sexton, G., Averbuck, M., Grossman, M., Wilson, D., Upson, B. (1990) Homocyst(e)inemia in daily practice: levels in coronary artery disease. Journal of American College of Cardiologists, 1, 215220.
  • Malinow, M.R., Boston, A.G., Krauss, R.M. (1999) Homocysteine, diet and cardiovascular diseases: a statement for healthcare professions from the Nutrition Committee. American Heart Association Circulation, 99, 178182.
  • Matthews, R.G. & Haywood, B.J. (1979) Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: some mechanistic and regulatory implications. Biochemistry, 18, 48454851.
  • Meyer, L.M. (1947) Folic acid in the treatment of pernicious anemia. Blood, 2, 5062.
  • Mills, J.L. (2000) Fortification of foods with folic acid – how much is enough. New England Journal of Medicine, 341, 14421446.
  • Mitchell, H.K., Snell, E.E., Williams, R.J. (1941) The concentration of ‘folic acid’. Journal of the American Chemical Society, 63, 2284.
  • Moore, C.V., Bierbaum, O.S., Welch, A.D., Wright, L.D. (1945The activity of synthetic Lactobacillus carei factor (‘folic acid’) as an antipernicious anemia substance. I. Observations on four patients, two with Addisonian perivirus anemias, one with nontropical sprue and one with pernicious anemia of pregnancy. Journal of Laboratory and Clinical Medicine, 30, 10561069.
  • Morrison, H.I., Schaubeh, D., Desmeulas, M., Wigle, D.T. (1996) Serum folate and risk of fatal coronary heart disease. Journal of the American Medical Association, 275, 18931896.
  • MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet, 338, 131137.
  • Mudd, S.H. (1988) Vascular disease and homocysteine metabolism. In: Genetic Susceptibility to Environmental Factors – a Challenge for Public Intervention (ed. by U.Smith, S.Eriksson & F. Lindgarde), pp. 1124. Almqvist and Wiksell, Stockholm.
  • Mudd, S.H., Finkelstein, J.D., Irreverre, F., Laster, L. (1964) Homocysteinuria: an enzymatic defect. Science, 143, 14431445.
  • Mudd, S.H., Levy, H.L., Abeles, R.H. (1969) A derangement in B12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria. Biochimical Biophysical Research Communications, 35, 121126.
  • Noronha, J.M. & Silverman, M. (1962) On folic acid, vitamin B12, methionine and forminoglutamic acid metabolism. In: Vitamin B12 and Intrinsic Factor (ed.by H.C.Heinrich), pp. 728736. Enke, Stuttgart.
  • Perry, D.J. (2000) Hyperhomocysteinaemia. Clinical Haematology, 12, 451477.
  • Pfiffner, J.J., Calkins, D.G., Bloom. E.S., O'Dell, B.L. (1946) On the peptide nature of vitamin Bc conjugate from yeast (Letter). Journal of the American Chemical Society, 68, 1392.
  • Refsum, H., Ueland, P.M., Swardal, A.M. (1989) Fully automated fluorescence assay for determining total homocysteine in plasma. Clinical Chemistry, 35, 19211927.
  • Rickes, E.L., Brink, N.G., Koniuszy, F.R., Wood, T.R., Folkers, K. (1948) Crystalline vitamin B12. Science, 107, 396397.
  • Roe, D.A. (1978) Lucy Wills (1888–1964): a biographical sketch. Journal of Nutrition, 108, 13791383.
  • Rosenberg, I.H. (1996) Homocysteine, vitamins and arterial occlusive disease: an overview. Journal of Nutrition, 1126, 1235512370.
  • Rosenblatt, D.S. (1989) Inherited disorders of folate transport and metabolism. In: Basis of Inherited Disease (ed. by C.R.Scriver, A.L.Beaudet, W.Sly & D. Valle), pp. 821844. McGraw-Hill, New York.
  • Scott, J.M. & Weir, D.G. (1998) Role of folic acid/folate in pregnancy: prevention is better than cure. In: Recent Advances in Obstetrics and Gynaecology (ed.by J.Bonnar) Ch 1, pp. 120. Churchill Livingstone, Edinburgh.
  • Scott, J.M., Weir, D.G., Kirke, P.N. (1995) Folate and neural tube defects. In: Folate in Health and Disease (ed.by L.B.Bailey) 12, pp. 329360. Marcel Dekker, New York.
  • Selhub, J., Jacques, P.F., Bostom, A.G. (1995) Association between plasma homocysteine concentrations and extracranial carotid artery disease. New England Journal of Medicine, 332, 286291.
  • Shane, B. (1989) Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitamins and Hormones, 45, 263335.
  • Shields, D.C., Kirke, P.N., Mills, J.L., Ramsbottom, D., Molloy, A.M., Burke, H., Weir, D.G., Scott, J.M., Whitehead, A.S. (1999) Thermolabile variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. American Journal of Human Genetics, 64, 10451055.
  • Smith, E.L. & ParkerVIII, L.F.J. (1948) Purification of anti-pernicious anaemia factor. Biochemical Journal, 43, VIII.
  • Smithells, R.W., Sheppard, S., Schorah, C.J. (1976) Vitamin deficiencies and neural tube defects. Archives of Diseases of Childhood, 51, 944950.
  • Snell, E.E. & Peterson, W.H. (1940) Growth factors for bacteria. X. Additional factors required by certain lactic acid bacteria. Journal of Bacteriology, 39, 273285.
  • Stabler, S.P., Marrell, P.D., Podell, E.R., Allen, R.H. (1987) Quantitation of total homocysteine, total cysteine and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Analytical Biochemistry, 162, 185196.
  • Stokstad, E.L.R. (1979) Early work with folic acid. Federation Proceedings, 38, 26962698.
  • Stokstad, E.L.R. & Manning, P.D.V. (1938) Evidence of a new growth factor required by chicks. Journal of Biological Chemistry, 125, 687697.
  • Surtees, R., Leonard, J., Austin, S. (1991) Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of methyl transfer pathway. Lancet, 338, 15501554.
  • Ubbink, J.B., Vermauk, W.J.H., Bennett, J.M., Becker, P.G., Van Staden, D.A., Bissbort, S. (1991) The prevalence of homocysteinaemia and hypercholesterolemia in angiographically defined coronary heart disease. Klinische Wochenschrifte, 69, 527534.
  • Van der Putt, N.M.J., Steegers-Theunissen, R.P.M., Frosst, P., Trijbels, F.J.M., Eskes, T.K.A.B., Van Den Heuvel, L.P., Mariman, E.C.M., Den Heger, M., Rozen, R., Blom, H.J. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 346, 10701071.
  • Vaughan, J. (1932) Tropical macrocytic anaemia. In: Proceedings of the Royal Society of Medicine, (Discussion of Paper by L. Wills), 25, 122.
  • Vaughan, J.M. (1934) The Anaemias. Oxford University Press, London.
  • Verhoef, P., Stampfer, M.J., Buning, J.E., Gaziano, J.M., Allen, R.H., Stabler, S.P., Reynolds, R.D., Kok, F.J., Hennekens, C.H., Willett, W.C. (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. American Journal of Epidemiology, 143, 845849.
  • Verneulen, E.G.J., Stehouser, C.D.A., Twisk, J.W.R., Van Den Berg, M., De Jong, S.C., Mackaay, A.J.C., Van Campen, C.M.C., Visser, F.C., Jakobs, C.A.J.M., Bulterijs, E.J., Rauwerda, J.A. (2000) Effect of homocysteine lowering treatment with folic acid plus vitamin B6 on progression of subclinical artherosclerosis: a randomised placebo-controlled trial. Lancet, 355, 517522.
  • Vilter, C.F., Vilter, R.W., Spies, T.D. (1946) Occurrence of combined system disease in persons with pernicious anemia during treatment with Lactobacillus casei factor (‘folic acid’). Proceedings of the Central Society of Clinical Research, 19, 609630.
  • Vilter, R.W., Spies, T.D., Koch, M.V. (1945) Further studies on folic acid in the treatment of macrocytic anemia. 5th Medical Journal (Nashville), 38, 781785.
  • Wagner, C., Briggs, W.T., Cook, R.J. (1985) Inhibition of glycine N-methyltransferase by folate derivatives: implications for regulation of methyl group metabolism. Biochemical Biophysical Research Communication, 127, 746752.
  • Watson, J. & Castle, W.B. (1943) Nutritional macrocytic anemia. Response to a substance other than the anti-pernicious anemia principle. Proceedings of the Society of Experimental Biology and Medicine, 58, 8486.
  • Weir, D.G. & Scott, J.M. (1995) The biochemical basis of the neuropathy in cobalamin deficiency. Clinical Haematology, 6, 479497.
  • Weir, D.G. & Scott, J.M. (1998a) Homocysteine as a risk factor for cardiovascular and related disease: nutritional implications. Nutrition Reviews, 11, 311338.
  • Weir, D.G. & Scott, J.M. (1998b) Colonic mucosal folate concentrations and their association with colorectal cancer. American Journal of Clinical Nutrition, 68, 763764.
  • Weir, D.G. & Molloy, A.M. (2000) Microvascular disease and dementia in the elderly: are they related to hyperhomocysteinaemia? American Journal of Clinical Nutrition, 71, 859860.
  • Welch, G.N. & Loscalzo, J. (1998) Homocysteine and artherothrombosis. New England Journal of Medicine, 338, 10421050.
  • Whitehead, A.S., Gallagher, P., Mills, J.L., Kirke, P.N., Burke, H., Molloy, A.M., Weir, D.G., Sheilds, D.C., Scott, J.M. (1995) A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Quarterly Journal of Medicine, 88, 763766.
  • Wickramasinghe, S.N. (1995) Morphology, biology and biochemistry of cobalamin – and folate deficient bone marrow cells. Clinical Haematology, 8, 441460.
  • Wickremasinghe, R.G. & Hoffbrand, A.V. (1980) Reduced rate of replication fork movement in megaloblastic anemia. Journal of Clinical Investigation, 65, 2636.
  • Wilken, D.E.L. & Wilken, B. (1976) The pathogenesis of coronary artery disease: a possible role for methionine metabolism. Journal of Clinical Investigation, 57, 10791082.
  • Wills, L. (1931) Treatment of ‘pernicious anaemia of pregnancy’ and ‘tropical anaemia’ with special reference to yeast extract as curative agent. British Medical Journal, 1, 10591064.
  • Wills, L. & Mehta, M.M. (1930) Studies in ‘pernicious anemia’ of pregnancy, I. preliminary report. Indian Journal of Medical Research, 17, 777792.
  • Wills, L. & Mehta, M.M. (1931) Studies in ‘pernicious anemia’ of pregnancy, Part IV. The production of pernicious anemia (Bartonella anemia) in intact albino rats by deficient feeding. Indian Journal of Medical Research, 18, 663683.
  • Wills, L. & Evans, B.D.F. (1938) Tropical macrocytic anaemia: its relation to pernicious anaemia. Lancet, ii, 416421.
  • Wright, L.D. & Welch, A.D. (1943) The production of folic acid by rat liver in vitro. Science, 98, 179182.